This application is filed pursuant to 35 U.S.C. .sctn. 371 as a United States National Phase Application of International Application No. PCT/EPO1/14887 filed Dec. 18, 2001, which claims priority from 0031109.2 filed Dec. 20, 2000.
The present invention relates to certain novel compounds. In